Amneal Pharmaceuticals(AMRX)
$21.38-0.32 (-1.47%)
AMRX
Amneal Pharmaceuticals earnings date
$21.38
At close:-0.32 (-1.47%)
Want to see AMRX full AI Analyst Report?
Amneal Pharmaceuticals (AMRX) Q2 2023 Earnings Report
634 Followers
AMRX Q2 2023 EPS Results
- Actual EPS
- $0.19
- Consensus EPS
- $0.10
- Beat/Miss
- Beat by +$0.09
- One Year Ago EPS
- $0.19
AMRX Q2 2023 Revenue Results
- Actual Revenue
- $599.05M
- Expected Revenue
- $565.14M
- Beat/Miss
- Beat by +$33.91M
- YoY Revenue Growth
- +7.10%
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 08/04/2023
- Time
- Before Open
- Conference Call
- Friday, August 4, 2023
AMRX Upcoming Earnings
Amneal Pharmaceuticals's next earnings date is estimated for February 26, 2027, based on past reporting schedules.
Q2 2023 Earnings Call Audio
AMRX Q2 2023 Earnings Call
0:00 / 0:00
Q2 2023 Earnings Slide Deck
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
AMRX Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 26, 2027 | 2026 (Q4) | 0.24- | 0.21 | ― | ― |
| Nov 03, 2026 | 2026 (Q3) | 0.240.26 | 0.17 | 52.94% (+0.09) | |
| Jul 30, 2026 | 2026 (Q2) | 0.220.30 | 0.25 | 20.00% (+0.05) | |
| May 07, 2026 | 2026 (Q1) | 0.170.27 | 0.21 | 28.57% (+0.06) | |
| Feb 27, 2026 | 2025 (Q4) | 0.180.21 | 0.12 | 75.00% (+0.09) | |
| Oct 30, 2025 | 2025 (Q3) | 0.140.17 | 0.16 | 6.25% (+0.01) | |
| Aug 05, 2025 | 2025 (Q2) | 0.170.25 | 0.16 | 56.25% (+0.09) | |
| May 02, 2025 | 2025 (Q1) | 0.150.21 | 0.14 | 50.00% (+0.07) | |
| Feb 28, 2025 | 2024 (Q4) | 0.150.12 | 0.14 | -14.29% (-0.02) | |
| Nov 08, 2024 | 2024 (Q3) | 0.130.16 | 0.19 | -15.79% (-0.03) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
